IM Cannabis (IMCC) Gains from Investment Securities (2024 - 2025)
IM Cannabis' (IMCC) quarterly Gains from Investment Securities came in at $204911.1 in Q3 2025, up 735.3% year-on-year from $24531.5 in Q3 2024, and up 227.22% quarter-over-quarter from -$161066.1 in Q4 2024.
IM Cannabis (IMCC) Gains from Investment Securities (2024 - 2025) Analysis & Trends
IM Cannabis' Gains from Investment Securities history runs 2 years deep, the most recent figure standing at $204911.1 for Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.55 Bn | 87.69 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.16 Bn | 1.97 Bn |
| 3 | Zoetis | 32.71 Bn | 30.77 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.65 Bn | 23.59 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.18 Bn | 21.03 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - |
| 7 | Viatris | 20.30 Bn | 18.50 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.84 Bn | 16.52 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn |
| 10 | IM Cannabis | 530,662.40 | -201,460.12 | 1.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 204,911.07 |
| Sep 30, 2025 | 204,911.07 |
| Dec 31, 2024 | -161,066.06 |
| Dec 31, 2024 | -161,066.06 |
| Sep 30, 2024 | -32,254.35 |
| Sep 30, 2024 | -32,254.35 |